Senators Markwayne Mullin (R-OK) and Bob Casey (D-PA), both members of the Senate Health, Education, Labor, and Pensions (HELP) Subcommittee on Children and Families, jointly introduced the Creating Hope Reauthorization Act late last week. This bipartisan legislation aims to ensure the continued development of drugs for treating rare pediatric diseases, including various forms of childhood cancer. Central to the bill is the extension of the Food and Drug Administration’s (FDA) Rare Pediatric Disease Priority Review Voucher (PRV) program, which incentivizes pharmaceutical companies to expedite …
